- Home
- EDAP vs ECOR Comparison
EDAP vs ECOR Comparison
Compare EDAP & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDAP
- ECOR
- Stock Information
- Founded
- EDAP 1979
- ECOR 2005
- Country
- EDAP France
- ECOR United States
- Employees
- EDAP N/A
- ECOR N/A
- Industry
- EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- EDAP Health Care
- ECOR Health Care
- Exchange
- EDAP Nasdaq
- ECOR Nasdaq
- Market Cap
- EDAP 53.8M
- ECOR 50.1M
- IPO Year
- EDAP 1997
- ECOR 2018
- Fundamental
- Price
- EDAP $1.70
- ECOR $5.22
- Analyst Decision
- EDAP Buy
- ECOR Strong Buy
- Analyst Count
- EDAP 3
- ECOR 2
- Target Price
- EDAP $8.50
- ECOR $25.50
- AVG Volume (30 Days)
- EDAP 27.6K
- ECOR 85.6K
- Earning Date
- EDAP 05-15-2025
- ECOR 08-06-2025
- Dividend Yield
- EDAP N/A
- ECOR N/A
- EPS Growth
- EDAP N/A
- ECOR N/A
- EPS
- EDAP N/A
- ECOR N/A
- Revenue
- EDAP $67,840,467.00
- ECOR $26,458,000.00
- Revenue This Year
- EDAP N/A
- ECOR $23.21
- Revenue Next Year
- EDAP N/A
- ECOR $44.10
- P/E Ratio
- EDAP N/A
- ECOR N/A
- Revenue Growth
- EDAP 3.69
- ECOR 41.54
- 52 Week Low
- EDAP $1.26
- ECOR $4.47
- 52 Week High
- EDAP $5.46
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- EDAP 40.81
- ECOR 45.50
- Support Level
- EDAP $1.63
- ECOR $5.05
- Resistance Level
- EDAP $1.79
- ECOR $5.81
- Average True Range (ATR)
- EDAP 0.09
- ECOR 0.32
- MACD
- EDAP -0.00
- ECOR 0.05
- Stochastic Oscillator
- EDAP 25.93
- ECOR 39.84
About EDAP EDAP TMS S.A.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.